Top 20 Pharma

Top 20 Pharmaceutical Companies

Based on 2009 pharma revenues.
Note: In all Top Company profiles, dollar amounts are in millions.

Slowing sales, mega-mergers, generic implosions and whipsawing exchange rates have caused some shakeups within the Top 20 Pharma ranks. The loss of Wyeth and Schering-Plough, coupled with Roche’s defection to the Biopharma list, led us to find several new players: Otsuka, Gilead and Mylan.
(Ver)

Gil Y. Roth, Editor

01 Pfizer $45,448

02 Sanofi-Aventis $40,871

03 Novartis $38,455

04 GlaxoSmithKline $36,746

05 AstraZeneca $31,905

06 Merck & Co. $26,929

07 Johnson & Johnson $22,520

08 Eli Lilly & Co. $20,629

09 Bristol-Myers Squibb $18,808

10 Abbott Laboratories $16,486

11 Takeda Chem. Ind. $14,204

12 Boehringer-Ingelheim $14,027

13 Teva Pharma $13,814

14 Bayer Schering $13,344

15 Astellas $10,509

16 Daiichi-Sankyo $9,757

17 Eisai $8,441

18 Otsuka $7,717

19 Gilead Sciences $6,469

20 Mylan $5,015